Switching of monoclonal antibodies against the calcitonin gene-related peptide or its receptor in migraine. Results from a Spanish Cohort

Background: Switching between calcitonin gene-related peptide (CGRP) and monoclonal antibodies (mAbs) may be a beneficial strategy after discontinuation. The aim of this study was to evaluate switching outcomes of effectiveness/tolerability. Methods: Retrospective multicentric study of migraine pati...

Full description

Saved in:
Bibliographic Details
Main Authors: J. Arzalluz-Luque, M. Millán Vázquez, R. Lamas Pérez, N. Sánchez Rodríguez, P. Gómez López, F.J. Gómez Fernández, J. Viguera Romero, C. Jurado Cobo, M. Fernández Recio, C. González Oria
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Neurology Perspectives
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667049624000255
Tags: Add Tag
No Tags, Be the first to tag this record!